Trial intelligence / Profile preview

Effects of ciprofol on perioperative immune function and inflammatory response in renal transplantation

ChiCTR2200060996Phase 4Not yet recruiting

Sponsor
Guangxi Medical University Second Affiliated Hospital
Start
Jun 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in end-stage kidney disease (ESKD) comparing Propofol arm with Ciprofol arm (2 arms). Primary endpoint: T cell lymphoid group. Planned start Jun 2022; status: not yet recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on ChiCTR2200060996.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200060996.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call